Independent Pharmacies Myths and Realities Analysis

This technical report analyzes the claims made by the independent pharmacy lobby regarding the financial stability and market position of independent pharmacies in the United States. It outlines the persistent warnings from the independent pharmacy sector about their impending demise, which have been proven false over time. The report details that independent pharmacies have maintained a stable market share of approximately 35% in the retail pharmacy sector for over a decade, despite competition from over 60,000 retail pharmacies. Furthermore, it presents evidence showing that independent pharmacies charge significantly higher prices than their competitors. The report also discusses the lobbying efforts of independent pharmacies, which aim to secure higher reimbursement rates, and argues that these demands could lead to increased healthcare costs for consumers. The findings underscore the need for policymakers to critically evaluate the claims made by the independent pharmacy lobby and consider the broader implications of their demands on healthcare pricing.